Đang chuẩn bị liên kết để tải về tài liệu:
UPAR enhances malignant potential of triple-negative breast cancer by directly interacting with uPA and IGF1R

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG Tải xuống

Due to lack of a targeted therapy for the triple-negative breast cancer (TNBC) patients, it is important to explore this aggressive breast cancer type in more detail and to establish novel therapeutic approaches. TNBC is defined negative for the protein expression of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). |